Polyneuron is a pharmaceutical company with a proprietary Antibody-Catch™ platform that enables the chemical design of injectable glycopolymers. These glycopolymers are designed to selectively eliminate autoantibodies in autoimmune disease patients, while leaving the immune system intact.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2014
  • Number of employees in Switzerland
    1-9
Key business